The activation of cGAS-STING exerts an antitumor role by inducing spontaneous antitumor immunity, enhancing senescence in premalignant cells, responding to classic cancer therapies, and inducing regulated cell death via IFN-dependent and IFN-independent pathways (41, 44)(Figures 3, 4). The gene discussed is STING1; the disease is cancer.